These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8267514)

  • 1. New NO-donors with antithrombotic and vasodilating activities, II: 3-alkyl-N-nitroso-5-sydnone imines.
    Rehse K; Schleifer KJ; Ciborski T; Bohn H
    Arch Pharm (Weinheim); 1993 Oct; 326(10):791-7. PubMed ID: 8267514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New NO-donors with antithrombotic activities and vasodilating activities, III: 3,4-disubstituted N-nitroso-5-sydnone imines.
    Rehse K; Schleifer KJ
    Arch Pharm (Weinheim); 1993 Dec; 326(12):929-39. PubMed ID: 8122963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New NO-donors with antithrombotic and vasodilating activities, I: 3-Arylalkyl-N-nitroso-5-sydnone imines.
    Rehse K; Kämpfe M; Schleifer KJ
    Arch Pharm (Weinheim); 1993 Aug; 326(8):483-7. PubMed ID: 8215847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New NO-donors with antithrombotic and vasodilating activities, V: Oligonitroso sydnone imines.
    Rehse K; Schleifer KJ; Martens A; Kämpfe M
    Arch Pharm (Weinheim); 1994 Jun; 327(6):393-7. PubMed ID: 8048846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New NO-donors with antithrombotic and vasodilating activities, Part 14. 1,3,4-Triazol-1-oles.
    Rehse K; Piechocki D; Schober M; Scheffler H; Reitner N; Unsöld E
    Arch Pharm (Weinheim); 1996 Nov; 329(11):511-3. PubMed ID: 8997901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New NO-donors with antithrombotic and vasodilating activities, VIII: Benzothiazole-2(3H)-nitrosimines.
    Rehse K; Ciborski T; Lüdtke E
    Arch Pharm (Weinheim); 1994 Dec; 327(12):771-7. PubMed ID: 7872854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New NO-donors with antithrombotic and vasodilating activities, IX: Thiadiazole nitrosimines.
    Rehse K; Lüdtke E
    Arch Pharm (Weinheim); 1995 Jan; 328(1):17-20. PubMed ID: 7695468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New NO-donors with antithrombotic and vasodilating activities, VI: thiazole-2-nitrosimines.
    Rehse K; Lüdtke E
    Arch Pharm (Weinheim); 1994 Sep; 327(9):581-9. PubMed ID: 7979924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XIX: 4,4'-Phenylene-bis-sydnone imines.
    Rehse K; Kämpfe M; Martens A
    Arch Pharm (Weinheim); 1993 Mar; 326(3):163-6. PubMed ID: 8481095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New NO-donors with antithrombotic and vasodilating activities, XI: 2-Nitrosiminobenzimidazoles.
    Rehse K; Birkhofer G
    Arch Pharm (Weinheim); 1995 Jan; 328(1):77-80. PubMed ID: 7695476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New NO-donors with antithrombotic and vasodilating activities, Part 21. Pseudonitrosites and other azodioxides with vicinal electron acceptors.
    Rehse K; Herpel M
    Arch Pharm (Weinheim); 1998 Mar; 331(3):111-7. PubMed ID: 9557137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XX: 4,4',4''-(1,3,5)-benzene-tris-sydnone imines.
    Rehse K; Martens A
    Arch Pharm (Weinheim); 1993 Apr; 326(4):217-9. PubMed ID: 8494483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXI: 4,4'-Alkylene-bis-sydnone imines.
    Rehse K; Martens A
    Arch Pharm (Weinheim); 1993 May; 326(5):307-11. PubMed ID: 8328885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New NO-donors with antithrombotic and vasodilating activities, XII: Mesoionic oxatriazoles and related noncyclic nitrosohydrazine derivatives.
    Rehse K; König P
    Arch Pharm (Weinheim); 1995 Feb; 328(2):137-42. PubMed ID: 7726739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New NO donors with antithrombotic and vasodilating activities, Part 29. N-(1-cyanocyclohexyl)-C-phenylnitrones and glyoxaldinitrones.
    Camehn R; Rehse K
    Arch Pharm (Weinheim); 2000 May; 333(5):130-4. PubMed ID: 10863797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New NO-donors with antithrombotic and vasodilating activities, Part 19. Pseudonitroles and their dimeric azodioxides.
    Rehse K; Herpel M
    Arch Pharm (Weinheim); 1998 Feb; 331(2):79-84. PubMed ID: 9525092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NO donors with antithrombotic and vasodilating activities, Part 23. Organic azides.
    Satyanarayana K; Rehse K
    Arch Pharm (Weinheim); 1998 Jun; 331(6):207-10. PubMed ID: 9713253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New NO donors with antithrombotic and vasodilating activities, Part 24. Hydrazine derivatives.
    Rehse K; Shahrouri T
    Arch Pharm (Weinheim); 1998 Oct; 331(10):308-12. PubMed ID: 9844577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New NO-donors with antithrombotic and vasodilating activities, part 15 nitrolic acids.
    Rehse K; Herpel M; Piechocki D
    Arch Pharm (Weinheim); 1996 Feb; 329(2):83-6. PubMed ID: 8851471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New NO-donors with antithrombotic and vasodilating activities, Part 17. Arylazoamidoximes and 3-arylazo-1,2,4-oxadiazol-5-ones.
    Rehse K; Bade S; Harsdorf A; Clement B
    Arch Pharm (Weinheim); 1997 Dec; 330(12):392-8. PubMed ID: 9474899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.